Greenbrook TMS Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Loss for the year
Amortization
Depreciation
Interest expense
Interest income
Share-based compensation
Loss on extinguishment of loans
Gain on lender warrants
Loss on deferred share units
Operating activities:
Loss for the year
Adjusted for:
Amortization
Depreciation
Operating lease expense
Interest expense
Interest income
Share-based compensation
Loss (gain) on extinguishment of loan
Loss on settlements (note 12(d) and 12(e))
Credit facility amendment fee (note 10(a))
Neuronetics Note non-cash financing costs (note 10(a))
Gain on lender warrants (note 12(a))
(Gain) loss on deferred share units (note 12(b))
Gain on performance share units (note 12(c))
Loss on conversion instruments
Forgiveness of loan payable
Impairment loss
Accounts receivable
Prepaid expenses and other
Accounts payable and accrued liabilities
Other payables
Cash provided by (used in) operating activities
Net proceeds on issuance of common shares
Net proceeds on exercise of stock options
Interest paid
Broker warrants exercised
Finance costs incurred
Bank loans advanced
Bank loans repaid
Shareholder loans repaid
Principal repayment of lease liabilities
Net non-controlling interest loans advanced
Distribution to non-controlling interest
Cash provided by (used in) financing activities
Acquisitions, net of cash acquired
Change in restricted cash
Acquisition of subsidiary non-controlling interest
Non-controlling interest subsidiary investment
Deferred and contingent consideration paid
Purchase of property, plant and equipment
Interest received
Cash provided by (used in) investing activities
Increase (decrease) in cash
Cash, beginning of the year
Cash, end of the year
Impairment loss (note 7)
Change in non-cash operating working capital:
Accounts receivable
Prepaid expenses and other
Advance for research collaboration (note 14)
Other payables
Accounts payable and accrued liabilities
Interest paid
Interest received
Payment of operating lease liabilities
Operating activities
Financing activities:
Net proceeds on issuance of common shares (note 15)
Finance costs incurred (note 10(a))
Bank loans advanced
Bank loans repaid (note 10(a))
Promissory notes advanced (note 10(a) and note 11)
Promissory notes repaid (note 10(a))
Principal repayment of finance lease liabilities
Non-controlling interest loans advanced
Non-controlling interest loans repaid
Distribution to non-controlling interest
Financing activities
Investing activities:
Acquisition, net of cash acquired
Change in restricted cash
Acquisition of subsidiary non-controlling interest (note 24)
Deferred and contingent consideration paid (note 13)
Purchase of property, plant and equipment
Investing activities
Increase (decrease) in cash
Cash, beginning of the year
Cash, end of the year

Comments